Warminster, PA, United States of America

Vladimir R Muzykantov

This inventor holds 18 USPTO granted patents and 12 published patent applications and 1 EPO patent, primarily in Drug Delivery Technologies. Top assignees: University of Pennsylvania, Icahn School of Medicine at Mount Sinai, University of Virginia Patent Foundation. Active years: 1997-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir R Muzykantov. Retrieved from https://idiyas.com/inventor/vladimir-r-muzykantov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 61.1

 

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 212(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1997)
  • Warwick, PA (US) (2002 - 2015)
  • Warminster, PA (US) (2014 - 2017)
  • Bryn Athyn, PA (US) (2017 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Fusion Proteins
Antibodies
Drug Delivery
Targeted Carriers
Polymer Nanocarriers
Therapeutic Formulations
Intracellular Delivery
Oxidative Injury
Lysosomal Storage Disorders
Intravascular Clots
Endothelial Cells
Recombinant Therapeutics
18 patents (USPTO):Explore Patents

Title: Innovations of Vladimir R Muzykantov

Introduction

Vladimir R Muzykantov is a prominent inventor based in Warminster, PA (US). He has made significant contributions to the field of biomedical engineering, particularly in drug delivery systems. With a total of 18 patents to his name, his work focuses on enhancing the efficacy of treatments through innovative methods.

Latest Patents

Among his latest patents are compositions and methods for loading cargoes onto red blood cells. These innovations include novel antibodies, fragments, and fusion proteins that specifically bind to red blood cells via RHCE or Band 3. Additionally, he has developed compositions comprising red blood cells that are coupled with nanoparticles for drug delivery. These nanoparticles are designed to have a low shear modulus or low Young's modulus of less than 10 MPa and can be used for both in vivo and ex vivo treatment of diseases.

Career Highlights

Vladimir has worked at prestigious institutions such as the University of Pennsylvania and the University of Virginia. His research has significantly advanced the understanding of drug delivery mechanisms and the use of red blood cells as vehicles for therapeutic agents.

Collaborations

Some of his notable coworkers include Juan Carlos Murciano and Douglas B Cines. Their collaborative efforts have contributed to the development of innovative solutions in the biomedical field.

Conclusion

Vladimir R Muzykantov's work exemplifies the intersection of innovation and practical application in medicine. His patents and research continue to pave the way for advancements in drug delivery systems, showcasing the importance of creativity in scientific progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…